Hospital
Oswego Hospital
Oswego Hospital was paid $63.84M by Medicaid between Jan 2018 and Dec 2024, across 371 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 14% of everything it billed.
33Billing provider infoOSWEGO HOSPITAL
OSWEGO, NY 13126
OSWEGO, NY 13126
33aNPI1871678458assigned 10/25/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$63.84M
24GClaims1,246,303
24DCodes billed371
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#26 of 231
Median peer was paid$561K
This provider vs. median114×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,827 | $212K | |
| 2019 | 77,598 | $3.10M | |
| 2020 | 230,361 | $9.34M | |
| 2021 | 258,284 | $11.29M | |
| 2022 | 254,039 | $18.67M | |
| 2023 | 249,661 | $13.94M | |
| 2024incomplete | 165,533 | $7.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 59,063 | 55,287 | $9.20M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 8.7% | 42,919 | 26,285 | $5.53M |
| H0040 | Assertive community treatment program, per diem | 8.5% | 2,884 | 2,882 | $5.42M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 8.4% | 34,851 | 22,699 | $5.37M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.3% | 27,262 | 24,493 | $4.63M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.3% | 13,952 | 13,246 | $2.11M |
| 80053 | Comprehensive metabolic panel | 2.3% | 78,298 | 71,744 | $1.46M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.3% | 9,192 | 9,182 | $1.45M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.2% | 27,057 | 22,999 | $1.41M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.1% | 4,814 | 4,706 | $1.32M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.0% | 7,049 | 6,695 | $1.28M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.0% | 8,888 | 8,451 | $1.26M |
359 more codes
| 81025 | 1.7% | 7,419 | $1.08M | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 10,804 | $931K |
| 99214 | Doctor's office visit, returning patient (more involved) | 1.4% | 5,959 | $919K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.4% | 1,076 | $881K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 2,581 | $802K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.2% | 7,879 | $770K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 1.2% | 2,942 | $748K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 57,025 | $723K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.1% | 23,820 | $700K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 8,527 | $633K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 2,313 | $624K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 375 | $489K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,540 | $484K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,660 | $479K |
| 90837 | Psychotherapy session, about an hour | <1% | 3,404 | $464K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,153 | $441K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,747 | $394K |
| 12001 | <1% | 812 | $358K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 42,837 | $357K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 272 | $356K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,471 | $350K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,558 | $333K |
| 87631 | <1% | 3,839 | $324K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 9,150 | $316K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 10,881 | $292K |
| 59025 | Fetal non-stress test | <1% | 1,296 | $261K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 9,603 | $253K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 957 | $246K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 10,880 | $231K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,039 | $227K |
| 80061 | Lipid panel | <1% | 36,288 | $218K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 7,151 | $213K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 22,911 | $207K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 3,585 | $197K |
| 97162 | <1% | 1,263 | $190K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 73,834 | $182K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 626 | $174K |
| 99402 | <1% | 1,635 | $170K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,036 | $164K |
| 84439 | <1% | 19,446 | $162K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 5,304 | $151K |
| 82607 | <1% | 12,411 | $143K | |
| 99401 | <1% | 1,908 | $142K | |
| 29125 | <1% | 598 | $141K | |
| 87660 | <1% | 9,991 | $126K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,356 | $123K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 414 | $121K |
| 82728 | <1% | 9,353 | $119K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 19,775 | $114K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,434 | $109K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,413 | $104K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 769 | $101K |
| 76770 | <1% | 784 | $99K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 5,773 | $96K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,657 | $95K |
| 86481 | <1% | 1,825 | $92K | |
| 87480 | <1% | 7,617 | $91K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 368 | $88K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 1,808 | $88K |
| 87625 | <1% | 3,285 | $82K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,640 | $79K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 2,820 | $78K |
| 87510 | <1% | 6,698 | $76K | |
| 93320 | <1% | 245 | $74K | |
| 86003 | <1% | 849 | $71K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 375 | $70K |
| 76830 | Ultrasound, transvaginal | <1% | 1,354 | $68K |
| 71250 | <1% | 794 | $67K | |
| 93971 | <1% | 977 | $67K | |
| 84702 | <1% | 6,203 | $67K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 2,467 | $65K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 9,171 | $65K |
| 76641 | <1% | 2,475 | $64K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 413 | $64K |
| 83880 | <1% | 1,900 | $60K | |
| 97602 | <1% | 107 | $60K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 1,880 | $58K |
| 82746 | <1% | 4,860 | $56K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 210 | $55K |
| 84153 | <1% | 2,855 | $53K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 329 | $53K |
| 87522 | Neg quan hep c or qual rna | <1% | 1,150 | $52K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 543 | $48K |
| 90899 | <1% | 26 | $44K | |
| 83540 | <1% | 9,375 | $44K | |
| 12011 | <1% | 103 | $43K | |
| 90715 | <1% | 1,096 | $41K | |
| 76536 | <1% | 2,055 | $41K | |
| 77080 | <1% | 833 | $40K | |
| 86618 | <1% | 2,576 | $40K | |
| 97161 | <1% | 366 | $39K | |
| 83550 | <1% | 8,343 | $39K | |
| 86706 | <1% | 4,195 | $38K | |
| 86780 | <1% | 3,246 | $38K | |
| 83655 | <1% | 2,861 | $37K | |
| 86704 | <1% | 3,975 | $37K | |
| 86850 | <1% | 3,046 | $36K | |
| 71271 | <1% | 1,584 | $36K | |
| 93017 | <1% | 732 | $36K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 16 | $35K |
| 86708 | <1% | 3,852 | $35K | |
| 70486 | <1% | 215 | $32K | |
| 10060 | <1% | 103 | $32K | |
| 86900 | <1% | 3,142 | $31K | |
| 87486 | <1% | 1,132 | $30K | |
| 83735 | <1% | 8,074 | $30K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,131 | $29K |
| 87070 | <1% | 4,752 | $29K | |
| 86762 | <1% | 2,007 | $29K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,914 | $28K |
| 84144 | <1% | 1,319 | $28K | |
| 87077 | <1% | 5,169 | $27K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,002 | $27K |
| 82043 | <1% | 5,629 | $26K | |
| 81001 | <1% | 12,044 | $25K | |
| 99406 | <1% | 918 | $25K | |
| H2011 | Crisis intervention service, per 15 minutes | <1% | 127 | $24K |
| 87581 | <1% | 1,132 | $24K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 141 | $23K |
| 84403 | <1% | 860 | $23K | |
| 80074 | <1% | 808 | $22K | |
| 86140 | <1% | 6,779 | $22K | |
| 86696 | <1% | 1,394 | $22K | |
| 86803 | <1% | 2,404 | $22K | |
| 82784 | <1% | 1,652 | $21K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 13 | $21K |
| 87186 | <1% | 5,167 | $21K | |
| 87807 | <1% | 2,098 | $21K | |
| 85027 | <1% | 6,840 | $20K | |
| 87340 | <1% | 1,974 | $20K | |
| 81003 | <1% | 22,111 | $19K | |
| 84146 | <1% | 932 | $18K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 212 | $18K |
| 83001 | <1% | 944 | $18K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,588 | $18K |
| 12002 | <1% | 37 | $17K | |
| 84481 | <1% | 1,954 | $17K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,238 | $16K |
| 86038 | <1% | 3,171 | $16K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 165 | $15K |
| 77066 | Tomosynthesis, mammo | <1% | 269 | $15K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 9,527 | $15K |
| 72110 | <1% | 997 | $14K | |
| 80076 | <1% | 2,127 | $14K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 323 | $14K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,331 | $14K |
| 85610 | <1% | 7,039 | $14K | |
| 84550 | <1% | 3,373 | $14K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,036 | $14K |
| 85652 | <1% | 6,867 | $12K | |
| 86787 | <1% | 1,581 | $12K | |
| 86800 | <1% | 944 | $12K | |
| 86376 | <1% | 835 | $12K | |
| 88304 | <1% | 397 | $12K | |
| 93225 | <1% | 248 | $12K | |
| 74018 | <1% | 2,097 | $11K | |
| 83690 | <1% | 6,182 | $11K | |
| 99201 | <1% | 86 | $10K | |
| 73630 | <1% | 2,552 | $10K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,712 | $10K |
| 72100 | <1% | 1,352 | $10K | |
| 82248 | <1% | 2,541 | $10K | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 466 | $10K |
| 73564 | <1% | 1,270 | $10K | |
| 84480 | <1% | 1,758 | $10K | |
| 84425 | <1% | 648 | $9K | |
| 73562 | <1% | 1,487 | $9K | |
| 90686 | <1% | 213 | $9K | |
| 87081 | <1% | 4,333 | $9K | |
| 82550 | <1% | 2,386 | $9K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 81 | $9K |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 156 | $9K |
| 82150 | <1% | 2,546 | $8K | |
| 72072 | <1% | 538 | $8K | |
| 85730 | <1% | 4,174 | $8K | |
| 86665 | <1% | 375 | $8K | |
| 73130 | <1% | 2,098 | $7K | |
| G0168 | Wound closure utilizing tissue adhesive(s) only | <1% | 42 | $7K |
| 73610 | <1% | 2,202 | $7K | |
| 0099U | <1% | 287 | $7K | |
| 74019 | <1% | 843 | $7K | |
| 86255 | <1% | 1,254 | $6K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 311 | $6K |
| 82670 | <1% | 231 | $6K | |
| 82570 | <1% | 1,376 | $6K | |
| 73030 | <1% | 1,052 | $6K | |
| 86430 | <1% | 1,271 | $6K | |
| 77065 | Tomosynthesis, mammo | <1% | 129 | $6K |
| S5161 | Emergency response system; service fee, per month (excludes installation and testing) | <1% | 196 | $6K |
| 93880 | <1% | 43 | $5K | |
| 97597 | <1% | 16 | $5K | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 96 | $5K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 94 | $5K |
| 83002 | <1% | 290 | $5K | |
| 73502 | <1% | 858 | $5K | |
| 82950 | <1% | 1,015 | $5K | |
| 82962 | <1% | 2,300 | $5K | |
| 88312 | <1% | 508 | $5K | |
| 87328 | <1% | 376 | $5K | |
| 73110 | <1% | 1,416 | $5K | |
| 99223 | Prolong inpt eval add15 m | <1% | 85 | $5K |
| 84703 | <1% | 5,312 | $5K | |
| 86431 | <1% | 920 | $5K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 559 | $4K |
| 76870 | <1% | 70 | $4K | |
| 85379 | <1% | 1,897 | $4K | |
| 85007 | <1% | 3,947 | $4K | |
| 86141 | <1% | 423 | $4K | |
| 86617 | <1% | 238 | $4K | |
| 86592 | <1% | 1,355 | $4K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 14 | $4K |
| 69209 | <1% | 25 | $4K | |
| 87205 | <1% | 2,202 | $4K | |
| 84100 | <1% | 984 | $4K | |
| 73020 | <1% | 827 | $4K | |
| 82785 | <1% | 318 | $4K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 57 | $4K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 98 | $4K |
| 0012A | <1% | 127 | $4K | |
| 99254 | <1% | 57 | $4K | |
| 82947 | <1% | 863 | $4K | |
| 83615 | <1% | 903 | $4K | |
| 97014 | <1% | 162 | $4K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $3K |
| 86235 | <1% | 264 | $3K | |
| 77062 | <1% | 83 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,670 | $3K |
| 72141 | <1% | 12 | $3K | |
| 82803 | <1% | 80 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 27 | $3K |
| 72050 | <1% | 360 | $3K | |
| 99221 | <1% | 82 | $3K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 12 | $3K |
| 70491 | <1% | 12 | $3K | |
| 0011A | <1% | 122 | $3K | |
| 84484 | <1% | 5,143 | $3K | |
| 85044 | <1% | 1,811 | $3K | |
| 29130 | <1% | 12 | $2K | |
| G0426 | Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | <1% | 33 | $2K |
| 83516 | <1% | 208 | $2K | |
| 88142 | <1% | 105 | $2K | |
| 97163 | <1% | 13 | $2K | |
| 87653 | <1% | 71 | $2K | |
| H0049 | Alcohol and/or drug screening | <1% | 42 | $2K |
| 72040 | <1% | 222 | $2K | |
| 93226 | <1% | 26 | $2K | |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | <1% | 25 | $2K |
| 93351 | <1% | 79 | $2K | |
| 82274 | <1% | 558 | $2K | |
| G0378 | Hospital observation service, per hour | <1% | 13 | $2K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 213 | $2K |
| 80047 | <1% | 53 | $2K | |
| 83993 | <1% | 132 | $1K | |
| 73140 | <1% | 403 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,897 | $1K |
| 90688 | <1% | 45 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 14 | $1K |
| 82565 | <1% | 318 | $1K | |
| 93325 | <1% | 129 | $1K | |
| 86308 | <1% | 468 | $1K | |
| 84460 | <1% | 255 | $1K | |
| 84410 | <1% | 24 | $1K | |
| 82533 | <1% | 73 | $1K | |
| 83970 | <1% | 30 | $1K | |
| 71101 | <1% | 213 | $1K | |
| 80164 | <1% | 127 | $1K | |
| 82627 | <1% | 53 | $1K | |
| 87046 | <1% | 380 | $1K | |
| 99253 | <1% | 98 | $1K | |
| 87040 | <1% | 1,747 | $1K | |
| G0008 | Administration of influenza virus vaccine | <1% | 86 | $1K |
| 86769 | <1% | 63 | $1K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,162 | $1K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 56 | $822.55 |
| 99407 | <1% | 73 | $785.34 | |
| 84156 | <1% | 267 | $779.73 | |
| 99051 | <1% | 73 | $761.04 | |
| 94060 | <1% | 31 | $691.83 | |
| 84165 | <1% | 110 | $661.60 | |
| 0031A | <1% | 20 | $612.61 | |
| 88112 | <1% | 24 | $589.21 | |
| 82977 | <1% | 114 | $546.66 | |
| 99460 | <1% | 54 | $532.00 | |
| 80178 | <1% | 89 | $529.41 | |
| 96367 | <1% | 27 | $497.08 | |
| 90656 | <1% | 37 | $471.31 | |
| 89055 | <1% | 148 | $468.74 | |
| 80320 | <1% | 2,084 | $464.91 | |
| 84450 | <1% | 101 | $442.26 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 129 | $420.88 |
| 73590 | <1% | 123 | $400.67 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,453 | $365.26 |
| 0001A | <1% | 28 | $359.48 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 23 | $350.59 |
| 86200 | <1% | 41 | $338.03 | |
| 83605 | <1% | 1,953 | $332.77 | |
| 83498 | <1% | 13 | $327.40 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 8,687 | $319.29 |
| 0002A | <1% | 26 | $316.56 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $316.46 |
| 82390 | <1% | 41 | $290.64 | |
| 83525 | <1% | 25 | $289.17 | |
| 87338 | <1% | 38 | $288.27 | |
| 73100 | <1% | 17 | $261.92 | |
| 82951 | <1% | 37 | $256.86 | |
| 94726 | <1% | 17 | $241.10 | |
| 94729 | <1% | 17 | $239.55 | |
| Q3014 | Telehealth originating site facility fee | <1% | 31 | $237.51 |
| 86160 | <1% | 12 | $237.18 | |
| 73620 | <1% | 38 | $191.08 | |
| 81015 | <1% | 883 | $187.48 | |
| 76882 | <1% | 27 | $179.51 | |
| 82140 | <1% | 15 | $179.22 | |
| 86765 | <1% | 13 | $170.02 | |
| 84155 | <1% | 45 | $161.22 | |
| 82103 | <1% | 14 | $155.37 | |
| 99252 | <1% | 40 | $155.22 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,962 | $153.98 |
| 73090 | <1% | 58 | $153.47 | |
| 73070 | <1% | 69 | $152.40 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 991 | $149.96 |
| J2704 | Injection, propofol, 10 mg | <1% | 3,009 | $135.31 |
| 99462 | <1% | 27 | $134.40 | |
| 73600 | <1% | 13 | $107.47 | |
| 84479 | <1% | 149 | $102.63 | |
| 97802 | <1% | 26 | $87.49 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 469 | $70.88 |
| 82247 | <1% | 14 | $70.78 | |
| 82952 | <1% | 37 | $56.10 | |
| 83520 | <1% | 17 | $55.73 | |
| 73560 | <1% | 12 | $48.78 | |
| J1815 | Injection, insulin, per 5 units | <1% | 12 | $40.26 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,119 | $34.64 |
| 80329 | <1% | 2,477 | $23.42 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,124 | $19.69 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 590 | $17.34 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,457 | $17.20 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,189 | $17.08 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 388 | $16.71 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,121 | $14.79 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,237 | $13.36 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 573 | $12.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 83 | $11.16 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 334 | $8.53 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 554 | $6.76 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 456 | $6.38 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,882 | $4.33 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 843 | $3.32 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 123 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 28 | $0.00 |
| 87210 | 0% | 41 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 47 | $0.00 |
| 90785 | 0% | 14 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 14 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 158 | $0.00 |
| 96376 | 0% | 130 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 34 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 56 | $0.00 |
| 94760 | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARLOVIC, MICHAEL (PRESIDENT & CEO)